Basilea Pharmaceutica AG (OTCMKTS:BPMUF – Get Free Report)’s stock price reached a new 52-week high during trading on Monday . The stock traded as high as $44.45 and last traded at $44.45, with a volume of 0 shares traded. The stock had previously closed at $44.45.
Basilea Pharmaceutica Price Performance
The company’s 50 day simple moving average is $41.42 and its 200 day simple moving average is $41.42.
About Basilea Pharmaceutica
Basilea Pharmaceutica AG, a commercial-stage biopharmaceutical company, focuses on the development of products that address the medical needs in the therapeutic areas of oncology and anti-infectives. The company offers Cresemba, an intravenous and antifungal drug for the treatment of invasive aspergillosis and mucormycosis in the United States, and the European Union.
Featured Stories
- Five stocks we like better than Basilea Pharmaceutica
- Dividend King Proctor & Gamble Is A Buy On Post-Earnings Weakness
- High-Yield Texas Instruments Could Hit New Highs Soon
- The 3 Best Fintech Stocks to Buy Now
- Pagaya Technologies: An AI Fintech That Insiders Are Buying
- Best Stocks Under $5.00
- Higher Oil Prices Could Give NextEra’s Stock Earnings a Boost
Receive News & Ratings for Basilea Pharmaceutica Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Basilea Pharmaceutica and related companies with MarketBeat.com's FREE daily email newsletter.
